Related references
Note: Only part of the references are listed.Serum Hepcidin Is Associated With Presence of Plaque in Postmenopausal Women of a General Population
Tessel E. Galesloot et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice
Chiara Vecchi et al.
GASTROENTEROLOGY (2014)
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB
Thomas Sonnweber et al.
GUT (2014)
Testosterone Perturbs Systemic Iron Balance Through Activation of Epidermal Growth Factor Receptor Signaling in the Liver and Repression of Hepcidin
Chloe Latour et al.
HEPATOLOGY (2014)
Carotid Atherosclerosis and Incident Atrial Fibrillation
Karin Willeit et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Diurnal Rhythm rather than Dietary Iron Mediates Daily Hepcidin Variations
Charlotte C. M. Schaap et al.
CLINICAL CHEMISTRY (2013)
Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study
Wendy P. J. den Elzen et al.
HAEMATOLOGICA (2013)
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
Stefan Kiechl et al.
NATURE MEDICINE (2013)
Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients
Neelke C. van der Weerd et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Testing the Iron Hypothesis in a Mouse Model of Atherosclerosis
Leon Kautz et al.
CELL REPORTS (2013)
Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis
Omar Saeed et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Hepcidin Destabilizes Atherosclerotic Plaque Via Overactivating Macrophages After Erythrophagocytosis
Jing Jing Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Mechanisms of Mammalian Iron Homeostasis
Kostas Pantopoulos et al.
BIOCHEMISTRY (2012)
Hepatic acute phase proteins - Regulation by IL-6-and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling
Johannes G. Bode et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Inhibition of hepcidin transcription by growth factors
Julia B. Goodnough et al.
HEPATOLOGY (2012)
Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations
Luca Valenti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo
Maura Poli et al.
BLOOD (2011)
Serum hepcidin: reference ranges and biochemical correlates in the general population
Tessel E. Galesloot et al.
BLOOD (2011)
Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo
Igor Theurl et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients
C. Thomas et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2011)
Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations
Michela Traglia et al.
JOURNAL OF MEDICAL GENETICS (2011)
Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis
Takahiro Kuragano et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Two to Tango: Regulation of Mammalian Iron Metabolism
Matthias W. Hentze et al.
CELL (2010)
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications
Igor Theurl et al.
BLOOD (2009)
Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy
G. Weiss et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization
Joyce J. C. Kroot et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Soluble receptor activator of nuclear factor-κB ligand and risk for cardiovascular disease
Stefan Kiechl et al.
CIRCULATION (2007)
Distinct risk profiles of early and advanced atherosclerosis - Prospective results from the Bruneck Study
J Willeit et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
